HealthcareLisata jumps on FDA orphan drug status for liver cancer drugBy Helitra.com·September 6, 2024·1 min read Lisata jumps on FDA orphan drug status for liver cancer drug Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer drug FDA jumps Lisata liver orphan status Post navigation Previous storyAscendis raised to outperform by Oppenheimer ahead of drug launchNext storyEli Lilly bets $409M for AI-focused drug discovery (NYSE:LLY)
Fitness · HealthcareHow to Build Up to 40 Consecutive Pushups for Better Heart HealthNovember 10, 2026To protect your heart, your most powerful weapon might just be the humble pushup. In fact, if you can drop and knock out…
Fitness · HealthcareStill Breaking Out in Your 20s, 30s, or 40s? Dermatologists Explain WhyNovember 10, 2026Throughout my teenage years, I was blessedly acne-free. I experienced severe eczema, and for that, I thought the trade-off for my dryness and…
Fitness · HealthcareThink Barbell Curls Build the Biggest Arms? MRI Scans Show These 3 Moves Trigger More GrowthNovember 10, 2026If bigger biceps are a goal you’re after, traditional barbell curls may not necessarily be the best bang for your buck exercise. While…